SlideShare a Scribd company logo
1 of 1
Proposed model of grant application.
Krumholz H M Circ Cardiovasc Qual Outcomes 2013;6:507-
508
Copyright © American Heart Association

More Related Content

Viewers also liked

mi power point
mi power pointmi power point
mi power pointlynda02
 
Kejohanan pingpong terengganu tertutup 2011 individu
Kejohanan pingpong terengganu tertutup 2011 individuKejohanan pingpong terengganu tertutup 2011 individu
Kejohanan pingpong terengganu tertutup 2011 individurosmizai
 
Quality Assurance in the Social Services in Israel--Hebrew
Quality Assurance in the Social Services in Israel--HebrewQuality Assurance in the Social Services in Israel--Hebrew
Quality Assurance in the Social Services in Israel--Hebrewmjbinstitute
 
Sunrise TCKL Offices
Sunrise TCKL OfficesSunrise TCKL Offices
Sunrise TCKL OfficesRaymond Kelly
 
Deceitful decisions at stockholm convention
Deceitful decisions at stockholm conventionDeceitful decisions at stockholm convention
Deceitful decisions at stockholm conventionshreeramkannan
 

Viewers also liked (6)

mi power point
mi power pointmi power point
mi power point
 
Socomtaxi 2010
Socomtaxi   2010Socomtaxi   2010
Socomtaxi 2010
 
Kejohanan pingpong terengganu tertutup 2011 individu
Kejohanan pingpong terengganu tertutup 2011 individuKejohanan pingpong terengganu tertutup 2011 individu
Kejohanan pingpong terengganu tertutup 2011 individu
 
Quality Assurance in the Social Services in Israel--Hebrew
Quality Assurance in the Social Services in Israel--HebrewQuality Assurance in the Social Services in Israel--Hebrew
Quality Assurance in the Social Services in Israel--Hebrew
 
Sunrise TCKL Offices
Sunrise TCKL OfficesSunrise TCKL Offices
Sunrise TCKL Offices
 
Deceitful decisions at stockholm convention
Deceitful decisions at stockholm conventionDeceitful decisions at stockholm convention
Deceitful decisions at stockholm convention
 

More from Marilyn Mann

Comparative effectiveness randomized trial to improve stroke care delivery c...
Comparative effectiveness randomized trial to improve stroke care delivery  c...Comparative effectiveness randomized trial to improve stroke care delivery  c...
Comparative effectiveness randomized trial to improve stroke care delivery c...Marilyn Mann
 
Marilyn mann slides for qcor 2018 final
Marilyn mann slides for qcor 2018 finalMarilyn mann slides for qcor 2018 final
Marilyn mann slides for qcor 2018 finalMarilyn Mann
 
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACSODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACSMarilyn Mann
 
Patient Viewpoint on PCSK9 Inhibitors
Patient Viewpoint on PCSK9 InhibitorsPatient Viewpoint on PCSK9 Inhibitors
Patient Viewpoint on PCSK9 InhibitorsMarilyn Mann
 
2016 hope 3 cognitive outcomes slides
2016 hope 3 cognitive outcomes slides2016 hope 3 cognitive outcomes slides
2016 hope 3 cognitive outcomes slidesMarilyn Mann
 
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...Marilyn Mann
 
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.Marilyn Mann
 
Complaint in hdl v johnson and dent
Complaint in hdl v johnson and dentComplaint in hdl v johnson and dent
Complaint in hdl v johnson and dentMarilyn Mann
 
Center Scope Fall 2014
Center Scope Fall 2014Center Scope Fall 2014
Center Scope Fall 2014Marilyn Mann
 
Ph rma principlesforresponsibleclinicaltrialdatasharing
Ph rma principlesforresponsibleclinicaltrialdatasharingPh rma principlesforresponsibleclinicaltrialdatasharing
Ph rma principlesforresponsibleclinicaltrialdatasharingMarilyn Mann
 
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...Marilyn Mann
 
Ema q & a on mipomersen march 2013
Ema q & a on mipomersen march 2013Ema q & a on mipomersen march 2013
Ema q & a on mipomersen march 2013Marilyn Mann
 
Ema scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersenEma scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersenMarilyn Mann
 
Oxman et al a surrealistic mega analysis of redisorganization theories
Oxman et al a surrealistic mega analysis of redisorganization theoriesOxman et al a surrealistic mega analysis of redisorganization theories
Oxman et al a surrealistic mega analysis of redisorganization theoriesMarilyn Mann
 
Glasziou taking healthcare interventions from trial to practice
Glasziou taking healthcare interventions from trial to practiceGlasziou taking healthcare interventions from trial to practice
Glasziou taking healthcare interventions from trial to practiceMarilyn Mann
 
Ioannidis why science is not necessarily self correcting
Ioannidis why science is not necessarily self correctingIoannidis why science is not necessarily self correcting
Ioannidis why science is not necessarily self correctingMarilyn Mann
 
Cer symposium 2012_ioannidis
Cer symposium 2012_ioannidisCer symposium 2012_ioannidis
Cer symposium 2012_ioannidisMarilyn Mann
 
Ema q & a on mipomersen
Ema q & a on mipomersenEma q & a on mipomersen
Ema q & a on mipomersenMarilyn Mann
 
Involveconference2 121120053215-phpapp02
Involveconference2 121120053215-phpapp02Involveconference2 121120053215-phpapp02
Involveconference2 121120053215-phpapp02Marilyn Mann
 

More from Marilyn Mann (20)

Comparative effectiveness randomized trial to improve stroke care delivery c...
Comparative effectiveness randomized trial to improve stroke care delivery  c...Comparative effectiveness randomized trial to improve stroke care delivery  c...
Comparative effectiveness randomized trial to improve stroke care delivery c...
 
Marilyn mann slides for qcor 2018 final
Marilyn mann slides for qcor 2018 finalMarilyn mann slides for qcor 2018 final
Marilyn mann slides for qcor 2018 final
 
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACSODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
ODYSSEY Outcomes: Cardiovascular Outcomes with Alirocumab after ACS
 
Patient Viewpoint on PCSK9 Inhibitors
Patient Viewpoint on PCSK9 InhibitorsPatient Viewpoint on PCSK9 Inhibitors
Patient Viewpoint on PCSK9 Inhibitors
 
2016 hope 3 cognitive outcomes slides
2016 hope 3 cognitive outcomes slides2016 hope 3 cognitive outcomes slides
2016 hope 3 cognitive outcomes slides
 
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...
 
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.
 
Complaint in hdl v johnson and dent
Complaint in hdl v johnson and dentComplaint in hdl v johnson and dent
Complaint in hdl v johnson and dent
 
Center Scope Fall 2014
Center Scope Fall 2014Center Scope Fall 2014
Center Scope Fall 2014
 
Improve it slides
Improve it slidesImprove it slides
Improve it slides
 
Ph rma principlesforresponsibleclinicaltrialdatasharing
Ph rma principlesforresponsibleclinicaltrialdatasharingPh rma principlesforresponsibleclinicaltrialdatasharing
Ph rma principlesforresponsibleclinicaltrialdatasharing
 
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...
 
Ema q & a on mipomersen march 2013
Ema q & a on mipomersen march 2013Ema q & a on mipomersen march 2013
Ema q & a on mipomersen march 2013
 
Ema scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersenEma scientific conclusions and grounds for refusal of mipomersen
Ema scientific conclusions and grounds for refusal of mipomersen
 
Oxman et al a surrealistic mega analysis of redisorganization theories
Oxman et al a surrealistic mega analysis of redisorganization theoriesOxman et al a surrealistic mega analysis of redisorganization theories
Oxman et al a surrealistic mega analysis of redisorganization theories
 
Glasziou taking healthcare interventions from trial to practice
Glasziou taking healthcare interventions from trial to practiceGlasziou taking healthcare interventions from trial to practice
Glasziou taking healthcare interventions from trial to practice
 
Ioannidis why science is not necessarily self correcting
Ioannidis why science is not necessarily self correctingIoannidis why science is not necessarily self correcting
Ioannidis why science is not necessarily self correcting
 
Cer symposium 2012_ioannidis
Cer symposium 2012_ioannidisCer symposium 2012_ioannidis
Cer symposium 2012_ioannidis
 
Ema q & a on mipomersen
Ema q & a on mipomersenEma q & a on mipomersen
Ema q & a on mipomersen
 
Involveconference2 121120053215-phpapp02
Involveconference2 121120053215-phpapp02Involveconference2 121120053215-phpapp02
Involveconference2 121120053215-phpapp02
 

Circ cardiovasc qual outcomes 2013 sep 6(5) 507 8, figure

  • 1. Proposed model of grant application. Krumholz H M Circ Cardiovasc Qual Outcomes 2013;6:507- 508 Copyright © American Heart Association

Editor's Notes

  1. Proposed model of grant application.